COVID-19, Research & Technology

Spectrum Health Enrolling Patients in Clinical Trial for Inpatient COVID-19 Treatment

Regeneron’s drug REGN-COV2 has shown improved symptoms in non-hospitalized COVID-19 patients.

GRAND RAPIDS Mich., Oct. 29, 2020 – Spectrum Health is partnering with Regeneron Pharmaceuticals to enroll patients into a clinical trial evaluating REGN-COV2, the company’s investigational antibody cocktail for the treatment and prevention of COVID-19.

Spectrum Health is the only health system in West Michigan and one of only two in the state to offer this trial, known as the aSPIKE trial, for hospitalized COVID-19 patients.

“Spectrum Health is participating in a trial to test the drug’s efficacy in hospitalized patients,” said Spectrum Health Research Physician Gordana Simeunovic, MD. “It is a randomized, double-blind trial that measures the effect of adding the drug to the usual standard-of-care treatment we use in our hospital, compared to adding a placebo.”

The trial is actively enrolling patients hospitalized at Spectrum Health Butterworth Hospital in Grand Rapids. To learn more, please contact

In addition to the trial in non-hospitalized patients, REGN-COV2 is currently being studied in a Phase 2/3 clinical trial for the treatment of COVID-19 in hospitalized patients, the Phase 3 open-label RECOVERY trial of hospitalized patients in the UK and a Phase 3 trial for the prevention of COVID-19 in household contacts of infected individuals.

Regeneron confirmed that President Trump received a dose of the company’s investigational COVID-19 antibody treatment, REGN-COV2, following a ‘compassionate use’ request from the President’s physicians.

For more information and data about the trial, please visit Regeneron.



People are at the heart of everything we do, and the inspiration for our legacy of outstanding outcomes, innovation, strong community partnerships, philanthropy and transparency. Corewell Health is a not-for-profit health system that provides health care and coverage with an exceptional team of 60,000+ dedicated people—including more than 11,500 physicians and advanced practice providers and more than 15,000 nurses providing care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities—and Priority Health, a provider-sponsored health plan serving more than 1.3 million members. Through experience and collaboration, we are reimagining a better, more equitable model of health and wellness. For more information, visit

Tim Hawkins
Media Relations
Office: 616.486.6091
Mobile: 616.443.0361